Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “HIV Infection”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT01775436
What this trial is testing

Palliative Care in People Living With HIV/AIDS: Integrating Into Standard of Care

Who this might be right for
HIV
Children's National Research Institute 444
Not applicableStudy completedNCT01048671
What this trial is testing

Management of Human Immunodeficiency Virus 1 (HIV-1) Participants Treated With Antiretroviral (ARV) Combination Therapy Including Raltegravir (MK-0518-138)

Who this might be right for
HIV Infections
Merck Sharp & Dohme LLC 482
Not applicableStudy completedNCT00001071
What this trial is testing

Stem Cells and Filgrastim

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 24
Not applicableStudy completedNCT00072644
What this trial is testing

Pharmacokinetic Interactions With Prednisolone in Healthy Volunteers and HIV-infected Patients Receiving Single-Dose Prednisone

Who this might be right for
Healthy
National Institutes of Health Clinical Center (CC) 75
Post-approval studies (Phase 4)Study completedNCT00068809
What this trial is testing

4-Day-A-Week Treatment Plan for HIV Infected Adolescents

Who this might be right for
HIV Infections
University of North Carolina, Chapel Hill 31
Not applicableStudy completedNCT00023387
What this trial is testing

TBTC Study 25PK: Intensive Pharmacokinetic Study of Three Doses of Rifapentine and 25-Desacetyl Rifapentine

Who this might be right for
Tuberculosis
Centers for Disease Control and Prevention 36
Post-approval studies (Phase 4)Study completedNCT00362687
What this trial is testing

GMB: Study of Truvada (TDF+FTC) or Emtricitabine (FTC) Alone Versus HAART Interruption in HIV-Infected Patients With Resistance

Who this might be right for
HIV Infections
Gilead Sciences 50
Post-approval studies (Phase 4)Study completedNCT01684787
What this trial is testing

Study to Evaluate the Treatment for Chronic Hepatitis C With Normal Transaminases in HIV Positive Patients

Who this might be right for
Chronic Hepatitis C
Miguel Santin 80
Post-approval studies (Phase 4)Ended earlyNCT01245101
What this trial is testing

Addition of Raltegravir to Established Antiretroviral Suppressive Therapy

Who this might be right for
HIV
University of Miami 15
Testing effectiveness (Phase 2)Study completedNCT02266992
What this trial is testing

Exploring Novel Mechanisms of Vaccine Failure LAIV Pilot Study

Who this might be right for
Acquired Immune Deficiency Syndrome Virus
Sheffield Teaching Hospitals NHS Foundation Trust 28
Not applicableActive Not RecruitingNCT02129244
What this trial is testing

A Nurse Case Management Intervention to Improve MDR-TB/HIV Co-Infection Outcomes

Who this might be right for
MDR-TBHIV
Johns Hopkins University 3,600
Not applicableStudy completedNCT03158844
What this trial is testing

HIV Care Cascade and Linkage to Antiretroviral Therapy Among Hospitalized Adults in Lusaka, Zambia

Who this might be right for
Hiv
University of Alabama at Birmingham 250
Not applicableStudy completedNCT01963234
What this trial is testing

Implementing Technology-Assisted Drug Treatment and Relapse Prevention in Federally Qualified Health Centers (FQHCs)

Who this might be right for
Substance Use DisordersHIV
University of Wisconsin, Madison 439
Large-scale testing (Phase 3)Study completedNCT01968551
What this trial is testing

Phase 3 Open-Label Study to Evaluate Switching From Optimized Stable Antiretroviral Regimens Containing Darunavir to Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide (E/C/F/TAF) Fixed Dose Combination (FDC) Plus Darunavir (DRV) in Treatment Experienced HIV-1 Positive Adults

Who this might be right for
HIV-1HIV InfectionsAcquired Immunodeficiency Syndrome
Gilead Sciences 158
Not applicableEnded earlyNCT04499651
What this trial is testing

Testing of a Navigation Intervention for Hepatitis C and HIV

Who this might be right for
HIV (Human Immunodeficiency Virus)Hepatitis C
University of California, Los Angeles 1
Early research (Phase 1)Study completedNCT00002353
What this trial is testing

A Phase I Safety and Immunogenicity Trial of UBI HIV Lipopeptide Immunotherapeutic P3C541b in HIV-1 Seropositive Human Subjects

Who this might be right for
HIV Infections
United Biomedical
Large-scale testing (Phase 3)Study completedNCT00002245
What this trial is testing

The Effects of Amprenavir, a Protease Inhibitor, on Carbohydrate and Fat Metabolism in HIV-Infected Patients

Who this might be right for
HIV Infections
Glaxo Wellcome
Not applicableNot Yet RecruitingNCT07608172
What this trial is testing

Short-Course Regimens for DS-PTB in AIDS Patients

Who this might be right for
Tuberculosis in HIV-infected IndividualsDrug Susceptible Pulmonary Tuberculosis
Shanghai Public Health Clinical Center 148
Testing effectiveness (Phase 2)WithdrawnNCT00488995
What this trial is testing

Safety And Efficacy Study Of CP-675,206 In HIV-Infected Patients

Who this might be right for
Human Immunodeficiency Virus
Pfizer
Not applicableStudy completedNCT00218712
What this trial is testing

Specialized Cognitive-Behavioral Counseling Intervention to Reduce HIV Transmission Risk Behavior in HIV-Infected Men

Who this might be right for
HIV Infections
University of California, San Francisco 488
Next Page